RxDoctor Payments Data

Reid Brown, MD

Orthopaedic Surgery · Louisville, KYNPI 1083616908

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $33,920 of the $41,656 with a category attached, or 81.4%. Smith+Nephew accounts for 98.7% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $39,705 and has fallen 99.7% since, to $125 in 2025.

$41,656in general payments, 2019–2025

Across 57 payments — averaging $730.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$41K
  • Pacira Pharmaceuticals Incorporated$214
  • Next Science LLC$176
  • Medacta USA, Inc.$40
  • Vertex$35
  • Innovation Technologies Inc$34
  • plus $56 from 4 others
$15,485in research payments, 2019–2025

Across 14 payments — averaging $1106.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$15K

What the payments were for

  • Consulting fees$1,0763%
  • Speaking & faculty fees$33,92081%
  • Travel & lodging$4,73211%
  • Food & beverage$1,9295%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$41,656 in reported general payments places this provider in the 85th percentile of 322 orthopaedic surgery providers in Kentucky.

See all orthopaedic surgery providers in Kentucky

Medicare billing

Part B allowed, 2024
$538,587
Medicare patients
768
Services billed
6,874

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen191$1,471
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen51$620
Cephalexin130$206
Ondansetron Hcl79$177
Meloxicam121$132
Pantoprazole Sodium63$118
Methylprednisolone15$71
Hydromorphone Hcl12$54
Tramadol Hcl11$22
Clindamycin Hcl16$13

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →